DE69806734T2 - Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel - Google Patents

Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel

Info

Publication number
DE69806734T2
DE69806734T2 DE69806734T DE69806734T DE69806734T2 DE 69806734 T2 DE69806734 T2 DE 69806734T2 DE 69806734 T DE69806734 T DE 69806734T DE 69806734 T DE69806734 T DE 69806734T DE 69806734 T2 DE69806734 T2 DE 69806734T2
Authority
DE
Germany
Prior art keywords
alkyl
alk
ch2oh
nr11r12
thiazolobenzoheterores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69806734T
Other languages
English (en)
Other versions
DE69806734D1 (de
Inventor
Jean-Claude Hardy
Jean Bouquerel
Patrick Nemecek
Jean-Claude Aloup
Serge Mignani
Jean-Francois Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69806734D1 publication Critical patent/DE69806734D1/de
Application granted granted Critical
Publication of DE69806734T2 publication Critical patent/DE69806734T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69806734T 1997-02-28 1998-02-26 Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel Expired - Lifetime DE69806734T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702436A FR2760237B1 (fr) 1997-02-28 1997-02-28 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
PCT/FR1998/000376 WO1998038194A1 (fr) 1997-02-28 1998-02-26 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
DE69806734D1 DE69806734D1 (de) 2002-08-29
DE69806734T2 true DE69806734T2 (de) 2002-12-05

Family

ID=9504307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69806734T Expired - Lifetime DE69806734T2 (de) 1997-02-28 1998-02-26 Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel

Country Status (10)

Country Link
EP (1) EP0966473B1 (de)
JP (1) JP4436460B2 (de)
AT (1) ATE221075T1 (de)
AU (1) AU6734598A (de)
DE (1) DE69806734T2 (de)
DK (1) DK0966473T3 (de)
ES (1) ES2180156T3 (de)
FR (1) FR2760237B1 (de)
PT (1) PT966473E (de)
WO (1) WO1998038194A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90269C2 (ru) 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
DE102005027168A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Tetrahydrochinoline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
JPS55111406A (en) * 1979-02-19 1980-08-28 Takeda Chem Ind Ltd Agent for controlling plant disease
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
HU210264B (en) * 1989-06-09 1995-03-28 Upjohn Co Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione

Also Published As

Publication number Publication date
EP0966473A1 (de) 1999-12-29
DK0966473T3 (da) 2002-11-18
FR2760237A1 (fr) 1998-09-04
FR2760237B1 (fr) 1999-04-16
ES2180156T3 (es) 2003-02-01
JP4436460B2 (ja) 2010-03-24
PT966473E (pt) 2002-12-31
DE69806734D1 (de) 2002-08-29
EP0966473B1 (de) 2002-07-24
ATE221075T1 (de) 2002-08-15
WO1998038194A1 (fr) 1998-09-03
JP2001517214A (ja) 2001-10-02
AU6734598A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
ES2173683T3 (es) Inhibidor del radical superoxido.
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
ES2213007T3 (es) Derivados de 4,5-diaril-3(2h)-furanona como inhibidores de la ciclooxigenasa-2.
NL300098I1 (nl) Thiophene sulfonamides useful as carbonic anhydrase inhibitors.
DK1022277T3 (da) Nye taxanderivater
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
ATE449069T1 (de) Aminopropanolderivate
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
KR890009875A (ko) 신규 화합물
DE69925824D1 (de) Glutathionderivate und dazugehörige dosisformen
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
ATE254104T1 (de) 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidin derivate als für den menschlichen nk3-rezeptor selektive antagonisten
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
ES2175155T3 (es) Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
DE69806734D1 (de) Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel
AR021826A1 (es) COMPUESTOS DE 2- FENILPIRAN-4-ONA, PROCESOS PARA PREPARARLOS, USO DE UN COMPUESTO INTERMEDIARIO EN DICHOS, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE Y USO DE DICHOS COMPUESTOS Y DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO
CA1268469C (en) PESTICIDES BASED ON PHOTOACTIVE BITHIENYL
FR2525597B1 (fr) Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
BR0108002A (pt) Derivados de amidas heterocìclicas
CY1105972T1 (el) ΝΕΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ [1,4] ΒΕΝΖΟΔΙΟΞΙΝΟ [2,3-e] ΙΣΟΪΝΔΟΛΙΟΥ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΑΥΤΩΝ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠEPΙΕΧΟΥΝ
BR0309462A (pt) Imidazopiridinas nitrosadas
EA200800208A1 (ru) Новые соединения 1h-индол-пиридинкарбоксамида и 1н-индол-пиперидинкарбоксамида, способ их получения и фармацевтические композиции, которые их содержат
GEP20084296B (en) Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC